研究氟喹诺酮类药物非那沙星对环丙沙星敏感和耐药鲍曼不动杆菌分离株的活性。
Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.
机构信息
Institute for Medical Microbiology, Immunology, and Hygiene, University of Cologne, Goldenfelsstrasse 19-21, 50935 Cologne, Germany.
出版信息
Antimicrob Agents Chemother. 2010 Apr;54(4):1613-5. doi: 10.1128/AAC.01637-09. Epub 2010 Jan 25.
This study compared the activity of finafloxacin, a novel fluoroquinolone which shows enhanced activity under acidic pH, and that of ciprofloxacin against Acinetobacter baumannii under standard conditions (pH 7.2) and at a pH of 5.8. Overall, finafloxacin demonstrated superior activity to ciprofloxacin under acidic conditions. Furthermore, finafloxacin showed comparable activity to ciprofloxacin at pH 7.2. Hence, finafloxacin could be a promising new antimicrobial agent for the treatment of A. baumannii infections at acidic body compartments.
本研究比较了法氟沙星（一种新型氟喹诺酮类药物，在酸性 pH 值条件下具有增强的活性）和环丙沙星在标准条件（pH7.2）和 pH5.8 下对鲍曼不动杆菌的活性。总的来说，法氟沙星在酸性条件下比环丙沙星具有更强的活性。此外，法氟沙星在 pH7.2 时与环丙沙星具有相当的活性。因此，法氟沙星可能是治疗酸性体腔鲍曼不动杆菌感染的一种有前途的新型抗菌药物。
Zotero 插件